Matches 1 - 50 out of 193 1 2 3 4 >


Match Document Document Title
US20090111761 Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions  
The present invention relates to the formulation and delivery of prostaglandin analogs to treat epithelial-related condition. In some embodiments, the compositions of the invention are used to...
US20070141162 Injectable compositions for the controlled delivery of pharmacologically active compound  
The present invention provides compositions and methods for extending the release times and lowering the toxicity of pharmacologically active compounds. The compounds comprise a salt of the...
US20070116649 Antibiotic formulations, unit doses, kits, and methods  
An aqueous or powder composition includes anti-gram-negative antibiotic or salt thereof being present at an amount ranging from about 100 mg/ml to about 200 mg/ml. Another aqueous or powder...
US20060153786 Compositions and methods for treating conditions of the nail unit  
The biodegradable drug delivery systems described here are formulated for implantation into the nail unit and its surrounding tissues for the treatment of various nail unit conditions. The systems...
US20060140990 Composition for topical treatment of mixed vaginal infections  
A pharmaceutical composition comprises (a) an antibacterial agent in an antibacterially effective amount, illustratively comprising clindamycin or a pharmaceutically acceptable salt or ester...
US20050207987 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics  
A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from...
US20050201947 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics  
A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from...
US20050130914 Methods of administering dalbavancin for treatment of skin and soft tissue infections  
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in...
US20140179625 SODIUM CHANNEL BLOCKERS  
The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
US20100099641 CRYSTALLINE FORM OF 1-CHOLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS  
The invention relates to a crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran -3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the...
US20080167255 4-BIARYLYL-1-PHENYLAZETIDIN-2-ONES  
4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formula in which represents an aryl or heteroaryl residue; Ar...
US20050130909 Dalbavancin compositions for treatment of bacterial infections  
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of a mixture of dalbavancin multimers and monomers for...
US20050090433 Dalbavancin compositions for treatment of bacterial infections  
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of a mixture of dalbavancin multimers and monomers for...
US20130137651 GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS  
The present invention relates to a solid powder composed of a mixture of a natural or a synthetic polymer which forms a gel, a buffer, such as an hydroxyacid or a dicarboxyacid, a saccharide, one...
US20070202055 Pharmaceutical Formulations  
An aspect of the present invention provides for a medicament suitable for administration as a nasal inhalant including an aqueous carrier and suspended therein particulate pleconaril, the aqueous...
US20140228287 1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-PIPERIDIN-1-YL]-AXANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL  
A pharmaceutical composition includes 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8 -[3-(R)-amino-piperidin-1-yl]-xanthine or a pharmaceutically acceptable form thereof as...
US20090137499 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE  
The present invention relates to a benzylphenyl glucopyranoside derivative having an excellent inhibitory effect on human SGLT1 and/or SGLT2 activity. There is provided a compound or a...
US20080108580 NOVEL AROMATIC FLUOROGLYCOSIDE DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THE USE THEREOF  
Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof. The invention relates to substituted aromatic fluoroglycoside derivatives of the formula I...
US20060142183 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections  
The present invention related to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant...
US20050008704 Pharmaceutical composition for solubility enhancement of hydrophobic drugs  
The present invention provides a pharmaceutical composition having enhanced solubility comprising a drug and polyethylene glycol, wherein the ratio of polyethylene glycol to drug by weight is from...
US20130184229 HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS  
Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating...
US20080214481 Methods of Treatment of Endobronchial Infections  
The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition...
US20070218038 STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED  
Bioimplants and methods of making the bioimplants are provided. The bioimplants comprise biological tissues having conjugated thereto adjunct molecules. The biological tissues are sterilized with...
US20050255048 Sprayable formulations for the treatment of acute inflammatory skin conditions  
A topical spray or foam, methods of making the formulation, and methods of use thereof, has been developed. In one preferred embodiment, the composition includes one or more active agents and...
US20050095205 Combination of loteprednol etabonate and tobramycin for topical ophthalmic use  
This invention relates to formulations for topical use comprising antibiotics in combination with anti-inflammatory steroids for treating ophthalmic infections and attendant inflammation. More...
US20070036731 Topical Delivery with a Carrier Fluid  
Aerosol spray formulations capable of delivering high concentrations of active agent-containing materials and/or excipient are described herein. The formulation contains a carrier fluid, a...
US20060292199 PMMA bone cement containing antibiotic/antibiotics  
A PMMA bone cement containing an antibiotic/antibiotics is described which is characterized in that, in the powder component, 0.1-5.0% by weight of water soluble, glasstype antibiotic/antibiotics...
US20160129036 ADENOSINE ANALOGS AND THEIR USE  
The invention provides adenosine analog compounds that act at P2Y receptors, e.g., the P2Y2 receptor, including pharmaceutical compositions; and uses thereof to treat or prevent diseases...
US20130274101 Synergistic Fungicidal Active Substance Combinations  
The novel active compound combinations of a carboxamide of the general formula (I) (group 1) in which R, G, R1 and A have the meanings given in the description and the active compound groups (2)...
US20070269385 DEVICES, METHODS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AGENTS FOR THE TREATMENT OF SINUSITIS, RHINITIS, AND OTHER DISORDERS  
Methods and kits for delivering pharmaceutical agents to the sinuses, sinus ostia, Eustachian tube, and pharynx are presented. A needle tip is translated through the mucosal tissue layer to a...
US20070202050 Pharmaceutical Formulations  
An aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically acceptable salt thereof, wherein at least one solvent comprising said...
US20110190199 Combination Therapy for Tuberculosis  
The present invention relates to methods of treating tuberculosis, including multi-drug resistant varieties and latent tuberculosis. More particularly, the present invention relates to a method of...
US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle  
The present invention relates in part to nettle extracts that are useful for treating or preventing seasonal allergies, allergic rhinitis, and other inflammatory conditions.
US20070161544 SELECTIVE TARGETING AGENTS FOR MITCOCHONDRIA  
The present invention relates to compositions and methods for providing mitochondria-selective targeting agents covalently linked to desired cargo such as radical scavenging agents. Compositions...
US20070141139 COMPOSITION FOR INTESTINAL DELIVERY  
The present invention relates to a new composition, use and method for oral administration to a human or an animal of a physiologically active agent comprising neutralizing agents to increase pH...
US20060222716 Colloidal solid lipid vehicle for pharmaceutical use  
The invention provides a drug carrier that includes a solid lipid nanoparticle (SLN), wherein the SLN includes tocopherol or a derivative thereof. The invention also provides a pharmaceutical...
US20050004049 Novel griseofulvin compositions  
The present invention is directed to nanoparticulate compositions comprising griseofulvin. The griseofulvin particles of the composition preferably have an effective average particle size of less...
US20070122490 Wound healing compound  
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprise a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or wound...
US20070098747 Topical pharmaceutical composition for the treatment of inflammatory dermatoses  
Provided is a topical pharmaceutical composition for the treatment of inflammatory dermatoses, including acne vulgaris, together with methods for its use. The composition and methods involve the...
US20070071686 Liquid preparation containing tobramycin  
The application describes a sterile aqueous inhalation solution containing the active agent tobramycin. The preparation has a high content of active agent (about 80 to 120 mg/ml of tobramycin) and...
US20060286146 Hemostatic compositons and methods  
The present invention provides methods and compositions involving resorbable hemostatic agents that have the essential absence of microfibrillar collagen. Resorbable hemostatic agents of the...
US20060045874 Aminoglycoside treatment for lysosomal storage diseases  
The present invention provides a method of treating lysosomal storage diseases such as Hurler syndrome and Batten disease in individuals in need of such treatment, comprising the step of...
US20140155263 Fungicidal Mixtures Based on Azolopyrimidinylamines  
Fungicidal mixtures comprising, as active components, 1) azolopyrimidinylamines of the formula I, in which the substituents are as defined in the description and 2) at least one active compound II...
US20050159369 Method of treatment of otitis externa  
This invention relates to a method of treating otitis externa using a topical combination medication, including one or more antifungal agent such as, for example fluconazole, voriconazole,...
US20160067296 Compositions and Methods for Joint Health  
The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness,...
US20120202762 METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES  
Methods are provided for using a compound to treat, for example, endothelial dysfunction including vascular abnormalities. More specifically, methods are described for using an oligosaccharide...
US20110038853 Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis  
The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in...
US20160367497 METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES  
Methods of treating or preventing axonal degradation in neuropathic diseases and neurological disorders in mammals are disclosed. The methods can comprise administering to the mammal an effective...
US20140178303 HETEROBIFUNCTIONAL PAN-SELECTIN INHIBITORS  
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the...
US20080044390 Methods and compositions for the treatment of neurodegenerative disorders  
The present invention features compositions, kits, and methods for treating, preventing, and ameliorating neurodegenerative disorders, e.g., Huntington's disease.

Matches 1 - 50 out of 193 1 2 3 4 >